Abstract |
To clarify the properties of BL-2401 ((+/-)-3-[2-benzyl-3-(propionylthio) propionyl]amino-5-methylbenzoic acid), a novel enkephalinase inhibitor, we examined its antinociceptive and antidepressant-like activities after oral administration, along with their association with endogenous opioid systems. BL-2401 produced an antinociceptive effect after oral administration in the mouse phenylbenzoquinone writhing test (ED50: 12.4 mg/kg) and the rat acetic acid writhing test (ED50: 55.8 mg/kg), the antinociceptive effect being antagonized by naloxone hydrochloride. BL-2401 also relieved arthritis-induced hyperalgesia in rats. In the mouse hot-plate and tail pressure tests, BL-2401 showed significant but modest antinociception at higher doses (200 and 400 mg/kg). In addition, BL-2401 (100 mg/kg) produced a naloxone-reversible antidepressant-like effect in the mouse forced swimming test. As for the mechanism of the action, the active metabolite of BL-2401, BL-2240 ((+/-)-3-(2-benzyl-3-mercaptopropionyl) amino-5-methylbenzoic acid), selectively inhibited enkephalinase in vitro (IC50: 5.2 nM). Oral administration of BL-2401 to mice significantly inhibited the enkephalinase activity in the striatum and also potentiated the antinociceptive effect of (D-Ala2,Met5)-enkephalin given intracisternally. These findings indicate that BL-2401 is an orally active enkephalinase inhibitor and may produce antinociceptive and antidepressant-like effects in association with endogenous opioid systems.
|
Authors | A Kita, K Imano, Y Seto, I Yakuo, T Deguchi, H Nakamura |
Journal | Japanese journal of pharmacology
(Jpn J Pharmacol)
Vol. 75
Issue 4
Pg. 337-46
(Dec 1997)
ISSN: 0021-5198 [Print] Japan |
PMID | 9469639
(Publication Type: Journal Article)
|
Chemical References |
- 3-(2-benzyl-3-(propionylthio)propionyl)amino-5-methybenzoic acid
- 3-(2-benzyl-3-mercaptopropionyl) amino-5-methylbenzoic acid
- Analgesics
- Analgesics, Opioid
- Antidepressive Agents
- Benzoates
- Benzoquinones
- Narcotic Antagonists
- Narcotics
- Sulfhydryl Compounds
- cassumunin A
- phenylbenzoquinone
- Naloxone
- Enkephalin, Methionine
- enkephalin-Met, Ala(2)-
- Neprilysin
- Curcumin
|
Topics |
- Administration, Oral
- Analgesics
(administration & dosage, pharmacology)
- Analgesics, Opioid
(pharmacology)
- Animals
- Antidepressive Agents
(administration & dosage, pharmacology)
- Benzoates
(administration & dosage, pharmacology)
- Benzoquinones
- Corpus Striatum
(drug effects, enzymology)
- Curcumin
(analogs & derivatives, isolation & purification, pharmacology)
- Dose-Response Relationship, Drug
- Drug Synergism
- Enkephalin, Methionine
(analogs & derivatives, pharmacology)
- Female
- Hyperalgesia
(chemically induced, drug therapy)
- Male
- Mice
- Naloxone
(pharmacology)
- Narcotic Antagonists
(pharmacology)
- Narcotics
(metabolism)
- Neprilysin
(antagonists & inhibitors)
- Pain
(chemically induced, drug therapy)
- Pain Measurement
- Rats
- Rats, Sprague-Dawley
- Rats, Wistar
- Sulfhydryl Compounds
(administration & dosage, pharmacology)
- Swimming
|